Repligen (RGEN) Change in Account Payables (2010 - 2026)
Repligen (RGEN) posted quarterly Change in Account Payables of $194000.0 for Q2 2026, up 112.25% year-over-year from $91402.7 in Q2 2025, and down 96.72% quarter-over-quarter from $5.9 million in Q1 2026.
Repligen (RGEN) Change in Account Payables (2010 - 2026) Analysis & Trends
Repligen (RGEN) has reported Change in Account Payables for 17 consecutive years, with $194000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Change in Account Payables rose 112.25% year-over-year to $194000.0; the TTM figure through Jun 2026 stood at $10.2 million (up 233.08% YoY), while the FY2025 annual figure was -$4.1 million, down 132.18% from the prior year.
- Change in Account Payables fell to $194000.0 in Q2 2026 per RGEN's latest filing, from $5.9 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $11.1 million in Q4 2024 and bottomed at -$16.4 million in Q3 2022.
- Historically, Change in Account Payables has averaged -$174444.4 across 5 years, with a median of $213500.0 in 2024.
- Annual changes were most pronounced in 2022 — Change in Account Payables plunged 2626.27% — and 2025, when it surged 1270.82%.
- Repligen's Change in Account Payables stood at $1.9 million in 2022, then plunged by 161.44% to -$1.2 million in 2023, then surged by 1039.02% to $11.1 million in 2024, then sank by 91.61% to $933000.0 in 2025, then slumped by 79.21% to $194000.0 in 2026.
- Business Quant data shows RGEN's Change in Account Payables at $194000.0 in Q2 2026, $5.9 million in Q1 2026, and $933000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | -52.50 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | - |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | - |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 83.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | -17.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | - |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -52.00 Mn |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | 194,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 194,000.00 |
| Jun 30, 2026 | 194,000.00 |
| Mar 31, 2026 | 5.92 Mn |
| Mar 31, 2026 | 5.92 Mn |
| Dec 31, 2025 | 933,000.00 |
| Dec 31, 2025 | 933,000.00 |
| Sep 30, 2025 | 3.19 Mn |
| Sep 30, 2025 | 3.19 Mn |
| Jun 30, 2025 | -1.58 Mn |
| Jun 30, 2025 | -1.58 Mn |
| Mar 31, 2025 | -6.69 Mn |
| Mar 31, 2025 | -6.69 Mn |
| Dec 31, 2024 | 11.12 Mn |
| Dec 31, 2024 | 11.12 Mn |
| Sep 30, 2024 | 233,000.00 |
| Sep 30, 2024 | 233,000.00 |
| Jun 30, 2024 | 2.19 Mn |
| Jun 30, 2024 | 2.19 Mn |
| Mar 31, 2024 | -645,000.00 |
| Mar 31, 2024 | -645,000.00 |